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The Ets-1 Transcription Factor Is Required
for the Development of Natural Killer Cells in Mice
as an important immunologic defense against tumor
cells and pathogen-infected cells that have down-regu-
lated endogenous class I MHC expression and are
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Christopher Fischer,* Chao-Nan Ting,*
Theresa L. Walunas,* Lewis L. Lanier,²
thereby invisible to class I MHC-restricted CTL (Karreand Jeffrey M. Leiden*³
et al., 1986; Liao et al., 1991). In addition to serving*Department of Medicine
as mediators of innate immunity against malignant andThe University of Chicago
virus-infected cells, NK cells have been implicated inChicago, Illinois 60637
bone marrow rejection (Ohlen et al., 1989; Yu et al., 1992;²Department of Immunobiology
Murphy et al., 1993).DNAX Research Institute of Molecular
During the last 5 years, a great deal has been learnedand Cellular Biology
about the signaling pathways and transcription factorsPalo Alto, California 94304
that regulate T cell ontogeny (Zuniga-Pflucker and Le-
nardo, 1996). In contrast, relatively little is known about
the molecular pathways that regulate NK cell develop-Summary
ment (Moore et al., 1996). The majority of NK cells de-
velop in the bone marrow and NK cell differentiationIn this report we have investigated the role of the Ets-1
has been shown to be dependent on the bone marrowtranscription factor in the differentiation of the NK cell
microenvironment (Moore et al., 1996). Recent studieslineage in mice. Splenic NK cells express high levels
have demonstrated that IL-15 produced by radio-resis-of Ets-1. Ets-1-deficient mice produced by gene tar-
tant cells in the bone marrow is required for NK cellgeting developed mature erythrocytes, monocytes, neu-
development in vivo (Ogasawara et al., 1998). This bonetrophils, and T and B lymphocytes. However, spleens
marrow±derived IL-15 binds to the IL-15 receptor on NKfrom the Ets-1-deficient mice contained significantly
cells, which is composed of a unique IL-15Ra chain andreduced numbers of natural killer (NK) cells, and sple-
common IL-2Rb and -g chains. Several other cytokinesnocytes from these mice lacked detectable cytolytic
including IL-2, IL-12, and IL-18 have also been impli-activity against NK cell targets in vitro. Moreover, un-
cated in the development of NK activity (Kobayashi etlike wild-type animals, Ets-1-deficient mice developed
al., 1989; Chan et al., 1992; Magram et al., 1996; Puzanovtumors following subcutaneous injection of NK-sus-
et al., 1996; Carson et al., 1997; Suzuki et al., 1997;ceptible RMA-S cells. These NK cell defects could not
Takeda et al., 1998).be correlated with defects in the expression of IL-12,
Ets-1 is a member of the Ets family of winged helix-IL-15, and IL-18 or the IL-2 or IL-15 receptors. Thus,
turn-helix transcription factors. Ets proteins bind to pu-Ets-1 defines a novel transcriptional pathway that is
rine-rich DNA motifs containing a conserved GGA core
required for the development of the NK cell lineage in
sequence and are important regulators of development
mice.
in flies, worms, and mammals (Crepieux et al., 1994;
Donaldson et al., 1996; Bassuk and Leiden, 1997).
Multiple Ets family members are expressed in lymphoidIntroduction
cells and many lymphoid-specific genes contain func-
tionally important Ets-binding sites (Bassuk and Leiden,Natural killer (NK) cells are cytotoxic lymphocytes that
1997). However, until recently the function of individualplay important roles in mammalian immune responses to
Ets proteins in regulating lymphocyte development re-tumor cells and cells infected with viruses, intracellular
mained unknown. In previous studies, we and othersbacteria, and parasites (Trinchieri, 1989; Bancroft, 1993;
used murine embryonic stem (ES) cells containing aMoore et al., 1996; Biron, 1997). Although NK cells and
targeted mutation of the Ets-1 gene in conjunction withT cells appear to differentiate from a common T/NK
the RAG2 complementation system to examine the roleprogenitor (Rodewald et al., 1992; Sanchez et al., 1994;
of Ets-1 in T and B cell development (Bories et al., 1995;Carlyle et al., 1997), NK cell cytolytic activity, unlike
Muthusamy et al., 1995). These studies demonstratedcytotoxic T cell (CTL)-mediated lysis, does not require
that Ets-1 is not required for the development of maturepresensitization, is not MHC restricted, and is not de-
single-positive (CD41 or CD81) T cells or IgM1B2201 Bpendent on rearranged antigen-specific receptor mole-
cells. However Ets-1-deficient T cells displayed a severecules such as the TCR (Gumperz and Parham, 1995).
defect in T cell antigen receptor (TCR)-mediated activa-Instead, most NK cells appear to recognize class I MHC-
tion. In addition, the Ets-12/2RAG22/2 animals devel-deficient target cells via polymorphic but nonrearrang-
oped increased numbers of splenic and lymph nodeing inhibitory receptors termed killer inhibitory receptors
plasma cells and displayed 5- to 10-fold elevated serum(KIR) and CD94/NKG2 in humans and Ly-49 in the mouse
IgM levels.(Lanier, 1997, 1998). Thus, NK cells appear to function
Although useful for studying the role of Ets-1 in T and
B cell development, the RAG2 complementation system³ To whom correspendence should be addressed (e-mail: jleiden@ did not allow us to assess the role of Ets-1 in the devel-medicine.bsd.uchicago.edu).
opment and function of other hematopoietic cell lin-§ Present address: Department of Medicine, Cardinal Bernadin Can-
eages in vivo. Accordingly, in the studies described incer Center, Loyola University Medical Center, Maywood, Illinois
60153. this report, we have used gene targeting to produce
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Figure 1. Ets-1 Expression in Splenic NK Cells and Generation of Ets-12/2 Mice
(A) Immunoblot analysis of Ets-1 expression in wild-type thymocytes and purified DX51CD32 splenic NK cells. Murine Ets-1 migrates as a
doublet in SDS-PAGE analysis (arrows).
(B) Generation of Ets-1-deficient mice. Top panels, schematic representation of the wild-type Ets-1 locus (top), the Ets-1 targeting vector
(middle), and the targeted Ets-1 allele (bottom). The targeting vector contains the neomycin resistance (neo) and the herpes simplex virus
thymidine kinase (HSV-tk) genes, both under the control of the PGK promoter. The 6.4 and 2.7 kb wild-type and 4.5 and 5.9 kb targeted alleles
are shown by arrows. Bottom left, Southern analysis of wild-type (1/1) and Ets-11/2 (1/2) ES cells. Bottom right, Southern analysis of offspring
from an Ets-11/2Ets-11/2 mating. The positions of the wild-type (wt) and targeted (t) alleles are shown to the left of each blot.
(C) Immunoblot analysis of Ets-1 expression in splenocytes from wild-type (1/1), heterozygous (1/2), and homozygous (2/2) Ets-1-deficient
animals.
mice containing a null mutation of the Ets-1 gene Results
(Ets-12/2 mice). Consistent with our previous results in
Expression of Ets-1 in Wild-Type NK Cellsthe Ets-12/2RAG22/2 chimeras, we find that Ets-1 is not
Previous studies have demonstrated that Ets-1 is ex-required for the development of mature T and B cells.
Moreover, we show that Ets-1 is not required for the pressed at high levels in mature B and T lymphocytes.
To determine if Ets-1 is also expressed in the closelydevelopment of the erythroid, myelomonocytic, or meg-
akaryocytic lineages. In contrast, Ets-1 appears to be related NK cell lineage, we performed Western blot anal-
yses on protein extracts derived from freshly isolatedessential for the development of mature NK cells in mice.
Ets-1-deficient mice contained markedly decreased purified DX51CD32 splenic NK cells. As shown in Figure
1A, Ets-1 was expressed in NK cells at levels equivalentnumbers of DX51CD32 splenic NK cells and displayed
severely reduced or absent NK cell function both in vitro to those observed in freshly isolated thymocytes. Murine
Ets-1 typically migrates as two bands in immunoblots.and in vivo. These defects in NK cell function could
not be rescued by culturing Ets-12/2 bone marrow with These bands may represent alternatively spliced and/
or differentially phosphorylated forms of the protein. Inexogenous IL-2, IL-12, or IL-15 and did not appear to
result from the lack of expression of either IL-18 or the the experiment shown in Figure 1A, NK cells appear
to contain relatively more slowly migrating Ets-1 thanIL-2 or IL-15 receptors. Taken together, these results
identify Ets-1 as an essential regulator of NK cell devel- thymocytes. However, this was not a consistent finding
in subsequent experiments (see, for example, Figure 1C;opment and define a novel Ets-1-dependent transcrip-
tional pathway that is required for NK cell differentiation data not shown) and its significance therefore remains
unclear.and/or survival.
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Figure 2. Lymphocyte Subsets in the Ets-1-
Deficient Animals
(A) B and T lymphocyte subsets in spleens
and thymi of wild-type (1/1) and Ets-1-defi-
cient (2/2) mice. Lymphocyte subsets were
quantitated by flow cytometry with antibod-
ies specific for CD4, CD8, IgM, and B220. The
data represents lymphocyte numbers from
four to seven animals in each group.
(B) Flow cytometric analysis of splenic T cells
(top), B cells (middle), and NK cells (bottom).
Note the significant reduction in DX51CD32
NK cells in the Ets-12/2 spleens. The percent-
age of cells in each quadrent is shown in each
panel.
(C) Numbers of DX51CD32 splenocytes in
wild-type (1/1) and Ets-1-deficient (2/2)
spleens. Data is shown as mean 6 SEM for
at least seven animals in each group.
(D) Serum IgM levels in age-matched wild-
type (1/1) and Ets-1-deficient (2/2) mice.
Production of Ets-1-Deficient Mice Analyses of B and T cell development in these mice
demonstrated the phenotypic characteristics observedTo better define the role of Ets-1 in the development
of non-B and -T cell hematopoietic lineages, we used previously in the Ets-12/2RAG22/2 chimeras (Bories et
al., 1995; Muthusamy et al., 1995). Thymocyte numbershomologous recombination in murine ES cells to pro-
duce a targeted deletion of exons 3 and 4 of the Ets-1 in 4- to 8-week-old Ets-12/2 mice were reduced by ap-
proximately 65% as compared to those of wild-typegene (Figure 1B). ES cells containing the Ets-1 mutation
were injected into wild-type C57BL/6 mouse blastocysts littermates (Figure 2A). However, the relative proportions
of double-negative (DN) (CD42CD82), double-positiveto produce chimeric mice, two of which transmitted the
targeted Ets-1 allele through the germ line. Mice hetero- (DP) (CD41CD81), and single-positive (SP) (CD41 and
CD81) thymocytes were not significantly different in thezygous for the targeted allele (Ets1/2) were identified
by Southern blot analysis (Figure 1B; data not shown). wild-type and Ets-1-deficient animals (Figure 2A; data
not shown). Unlike wild-type CD81 thymocytes, manyThese mice were interbred to produce Ets-1-deficient
animals (Ets-12/2) (Figure 1B). Immunoblot analyses of the Ets-12/2 CD81 thymocytes also expressed low
levels of CD4. The significance of this finding remainsdemonstrated the lack of detectable full-length or trun-
cated Ets-1 protein in splenocytes from the Ets-12/2 unclear. Numbers of Ets-12/2 SP splenic T cells were
slightly reduced and this reduction was more pro-mice (Figure 1C), suggesting that this targeting con-
struct had produced a null allele in these mice. nounced in the CD81 than in the CD41 population (Figure
2A). In addition, Ets-12/2 splenic T cells displayed aThe Ets-12/2 mice were viable and fertile. However,
they displayed an increased perinatal mortality. Ap- marked defect in activation following cross-linking of
the T cell antigen receptor (data not shown). Numbersproximately 50% of the Ets-12/2 pups survived until
weaning at 4 weeks of age. The cause of this premature of IgM1B2201 splenic B cells were normal in the Ets-12/2
mice (Figure 2A). However, these animals had increasedmortality is unclear and remains under investigation.
Adult Ets-12/2 mice contained normal numbers of pe- numbers of splenic and lymph node plasma cells and
serum IgM levels were elevated by approximately 5-foldripheral blood erythrocytes, monocytes, granulocytes,
and platelets (data not shown). (Figure 2D). Serum levels of the other Ig isotypes were
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Figure 3. NK Cytolytic Activity of Ets-1-Defi-
cient Splenocytes
In vitro cytotoxicity against YAC-1 (A) and
b2m2/2 lymphoid blasts (B) using unfraction-
ated poly (I:C)-stimulated splenocytes. Cyto-
toxicity assays were performed at effector to
target cell ratios (E:T) of 6.25:1 to 100:1. Data
are presented as mean 6 SEM for cells from
three different animals in each group.
normal (data not shown). Thus, Ets-1 does not appear to the lymph nodes and bone marrow of the Ets-12/2 mice
also did not contain detectable DX51CD32 cells (databe required for the development of mature erythrocytes,
neutrophils, monocytes, platelets, or B and T cells. How- not shown).
ever, in the absence of Ets-1 there is a modest reduction
in thymocyte numbers, mature T cells cannot be acti- Ets-1-Deficient Splenocytes Display Reduced NK
Cell Activity In Vitrovated normally through the TCR, and there appears to
be increased differentiation of B cells into IgM-secreting The severe reduction in the numbers of splenic NK cells
in the Ets-12/2 mice suggested that these mice mightplasma cells.
display defects in NK cell activity. Indeed, unlike wild-
type splenocytes, Ets-12/2 splenocytes were unable toEts-1 Is Required for NK Cell Development
To assess directly the role of Ets-1 in NK cell develop- lyse NK-susceptible YAC-1 tumor cells in vitro (Figure
3A). Consistent with previous reports, conconavalin A±stim-ment, freshly isolated splenocytes from wild-type or
Ets-12/2 mice were analyzed by two-color flow cytome- ulated lymphoid blasts from b2-microglobulin-deficient
(b2m2/2) mice, which lack cell-surface expression oftry using antibodies against CD3 and DX5. The majority
of mature NK cells in the spleen and bone marrow are class I MHC molecules, were lysed efficiently by wild-
type NK cells (Figure 3B) (Liao et al., 1991). In contrast,contained within the DX51CD32 population (DiSanto et
al., 1995). Although the epitope recognized by the DX5 Ets-12/2 splenocytes also failed to lyse these b2m2/2
lymphoid blasts in vitro (Figure 3B). The lack of NK-MAb remains unknown, it was used in these studies
because it detects most or all NK cells in both C57BL/6 mediated target cell lysis by unfractionated Ets-12/2
splenocytes might have reflected the absence of func-and 129 mice (the Ets-12/2 mice are in a mixed C57BL/
6-129 background). As shown in Figures 2B and 2C, the tional splenic NK cells or, alternatively, a reduction in
the numbers of NK cells in the spleens of these animals.numbers of splenic DX51CD32 NK cells were markedly
reduced in the Ets-12/2 animals as compared to their To distinguish these alternatives, we repeated the in
vitro NK cell cytolytic assays using purified DX51CD32wild-type littermates (p # 0.00001). Similar reductions
in NK cell numbers were observed when splenocytes splenocytes from wild-type and Ets-1-deficient mice.
DX51CD32 splenocytes from the Ets-1-deficient animalswere stained with antibodies against NK1.1 and CD3,
demonstrating that the defect in NK cell numbers did were purified at least 100-fold by flow cytometry (data
not shown). However, the cytolytic activity of these puri-not simply reflect a lack of expression of the DX5 epitope
on the Ets-1-deficient splenocytes (data not shown). fied cells against YAC-1 and RMA-S NK target cells
increased only minimally (Figures 4A and 4B). This resultHowever, the NK1.1 analysis was complicated by the
fact that only some of the C57BL/6-129 mixed back- suggested either that the residual DX51CD32 Ets-1-defi-
cient splenocytes were not bona fide NK cells (and in-ground mice inherited the NK1.1 allele, which is ex-
pressed on C57BL/6 but not on 129 NK cells. Finally, stead reflected low-level background staining with the
Figure 4. NK Cytolytic Activity of Purified
DX51CD32 Ets-1-Deficient NK Cells
In vitro cytotoxicity against YAC-1 (A) and
RMA-S (B) targets of purified poly (I:C)-stimu-
lated DX51CD32 splenic NK cells. Cytotoxic-
ity assays were performed at effector to tar-
get cell ratios (E:T) of 0.15:1 to 2.5:1. Data in
(A) is presented as mean 6 SEM for cells from
three different animals in each group. Data in
(B) represents values from a single animal in
each group.
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Figure 5. IFNg Production by Ets-1-Deficient Splenocytes
Wild-type (1/1) or Ets-1-deficient (2/2) splenocytes were stimu-
lated in vitro with poly (I:C) for 18 hr, and IFNg was measured in
culture supernatants by ELISA. Data is presented as mean 6 SEM
for cells from three different animals in each group.
DX5 antibody) or that these cells were not functional for
NK-mediated lysis.
NK cells are an important early source of IFNg follow-
ing pathogen invasion (Biron, 1997). In keeping with the
finding of markedly reduced numbers of splenic NK cells
in the Ets-1-deficient mice, Ets-12/2 splenocytes stimu-
lated with poly (I:C) in vitro produced significantly re-
Figure 6. In Vivo NK Cell Function in Ets-1-Deficient Miceduced amounts of IFNg as compared to wild-type con-
trol cells (Figure 5). Thus, two important in vitro NK cell (A) Photographs of representative wild-type (1/1) and Ets-1-defi-
cient (2/2) mice following subcutaneous injection with 105 RMA-Sfunctions, cytolysis of NK cell targets and IFNg produc-
tumor cells. Note the tumor in the right hindlimb of the Ets-1-defi-tion, were defective in the Ets-1-deficient animals.
cient mouse, which is not seen in the wild-type mouse injected with
the same cells.
Ets-1-Deficient Mice Display Defective NK (B) Incidence of tumors following injection of wild-type (n 5 9) and
Cell Activity In Vivo Ets-1-deficient (n 5 7) mice with 105 RMA-S cells.
The rejection of many class I MHC-deficient tumors is
dependent on intact NK cell function in vivo. One exam-
ple of such an NK cell±dependent class I MHC-deficient findings, flow cytometric analyses of splenocytes from
the Ets-1-deficient mice demonstrated high level ex-tumor is RMA-S (van den Broek et al., 1995). To deter-
mine if the defects in in vitro NK cell function observed pression of the IL-2Rb chain on CD81 T cells (Figure
7B). Activated T cells from the Ets-1-deficient mice alsoin the Ets-12/2 mice were reflected in abnormal NK cell
function in vivo, wild-type and Ets-12/2 mice were in- demonstrated normal expression of IL-2Ra and -g
chains by flow cytometry (data not shown). Furthermore,jected subcutaneously with 105 RMA-S cells and fol-
lowed for 40 days for tumor progression (Figure 6). None addition of exogenous IL-2 did not rescue the cytolytic
activity of Ets-12/2 bone marrow against YAC-1 targetsof the wild-type mice developed detectable tumors dur-
ing the 40 day time course of the experiment. In con- (Figure 7C).
IL-15 is produced by many cells including bone mar-trast, 6 of 7 Ets-12/2 animals developed subcutaneous
tumors $ 1 cm between 17 and 26 days after injection row stromal cells and activated monocytes and is
thought to be important for NK cell development (Puza-(Figure 6). Thus, Ets-1 appears to be necessary for the
development of normal NK activity as assayed both in nov et al., 1996; Carson et al., 1997). The IL-15 receptor
(IL-15R) is composed of a unique IL-15a chain in combi-vitro and in vivo.
nation with the IL-2Rb chain and the common g chain.
As described above, expression of the IL-2Rb and -gCytokines and Cytokine Receptors and the NK Cell
Defect of Ets-1-Deficient Mice chains were not significantly reduced in Ets-1-deficient
splenocytes, nor was expression of the IL-15Ra chainA number of cytokines have been implicated in the de-
velopment and function of NK cells. These include IL-2, (Figure 7A). Moreover, addition of exogenous IL-15 did
not rescue the cytolytic activity of Ets-12/2 bone marrowIL-12, IL-15, and IL-18. Accordingly, we studied the ex-
pression of these cytokines and their receptors in the cells against YAC-1 targets (Figure 7C). Similarly, addi-
tion of both IL-2 and IL-15 failed to restore the cytolyticEts-12/2 animals. Mice with a targeted mutation of the
b subunit of the IL-2 receptor (IL-2Rb) display a reduc- activity of Ets-12/2 bone marrow cells against YAC-1
targets (Figure 7C).tion in NK cell numbers and deficient NK cell±mediated
cytolytic activity (Suzuki et al., 1997). However, expres- IL-12 enhances NK cytolytic activity, induces secre-
tion of IFNg, and is mitogenic for T and NK cells (Koba-sion of both the IL-2Rb and common g chains were
normal in Ets-12/2 splenocytes as assessed by RNase yashi et al., 1989; Chan et al., 1992). IL-12 expression, as
measured by RNase protection assay, was moderatelyprotection assays (Figure 7A). Consistent with these
Immunity
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Figure 7. Cytokines and Cytokine Receptors and the NK Defect of Ets-1-Deficient Mice
(A) Expression of cytokine and cytokine receptor mRNAs in Ets-1 deficient poly (I:C)-stimulated splenocytes as determined by ribonuclease
protection assay. Values were normalized first to an internal GAPDH control in each sample and then to wild-type mRNA levels as described
in Experimental Procedures.
(B) Flow cytometric analysis of IL-2Rb expression on CD81 splenocytes from wild-type (1/1) and Ets-1-deficient (2/2) mice.
(C) Effect of exogenous cytokines on the in vitro cytotoxicity of wild-type (1/1) or Ets-1-deficient (2/2) bone marrow. All assays utilized
YAC-1 targets. Effector to target (E:T) ratios are shown. Data from two animals of each genotype are shown.
(D) Effect of exogenous IL-12 on the in vitro cytotoxicity of wild-type (1/1) and Ets-1-deficient (2/2) splenocytes. Data from one animal of
each genotype is shown.
reduced in poly (I:C)-stimulated Ets-12/2 splenocytes for the development of mature erythrocytes, neutrophils,
monocytes, megakaryocytes, or B and T lymphocytes,(Figure 7A). However, this reduction in IL-12 production
appears unlikely to account for the NK cell abnormalities but it is necessary for the development and/or survi-
seen in the Ets-12/2 mice for two reasons. First, unlike val of the NK cell lineage in mice. Ets-1-deficient mice
the Ets-1-deficient mice, IL-12 (p40)-deficient mice dis- contained significantly reduced splenic NK cells and
play only a modest reduction in NK cytolytic activity displayed markedly reduced NK cell cytolytic activity
(Magram et al., 1996). Moreover, addition of exogenous against both tumor cell and class I MHC-deficient tar-
IL-12 did not restore the cytolytic activity of Ets-1-defi- gets in vitro and in vivo. These defects in NK cell function
cient splenocytes against YAC-1 targets (Figure 7D). did not appear to reflect defective expression of either
Like IL-12, IL-18, which is secreted from activated mac- IL-18 or the IL-2 or IL-15 receptors and could not be
rophages, induces secretion of IFNg and enhances NK rescued by culturing Ets-12/2 bone marrow with exoge-
cell activity. Recently, IL-18-deficient mice have been nous cytokines IL-2, IL-12, or IL-15. Thus, Ets-1 appears
reported to display moderately reduced NK cell activity to define a novel transcriptional pathway that distin-
in vitro (Takeda et al., 1998). However, it appears unlikely guishes the development of the NK cell lineage from that
that deficiencies in the expression of IL-18 or IL-18R of closely related B and T lymphocytes. This pathway
were responsible for the NK cell phenotype seen in the appears to be different from those regulated by tran-
Ets-12/2 animals. Unlike the Ets-1-deficient mice, which scription factors such as Ikaros, which is required for
displayed markedly reduced numbers of splenic NK the development of all (B, T, and NK) lymphoid lineages
cells, the IL-182/2 mice contained normal numbers of (Georgopoulos et al., 1994).
NK cells in the spleen (Takeda et al., 1998). Second, The mechanism by which Ets-1 deficiency causes de-
as shown in Figure 7A, expression of IL-18 by Ets-1- fects in NK cell activity remains unclear. Our finding of
deficient splenocytes was normal. markedly reduced NK cells in the spleens of the Ets-
1-deficient mice strongly suggests that the functional
Discussion defect in NK activity seen in these animals reflects a
defect in the production and/or survival of mature NK
cells. However, the lack of lineage-specific markers thatIn the studies described in this report, we have demon-
strated that the Ets-1 transcription factor is not required allow the identification of specific populations of NK cell
Ets-1 and NK Cell Development
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precursors makes it difficult or impossible to precisely the molecular pathways underlying the development of
natural immunity in mammals.determine the stage at which NK cell development is
defective in the Ets-1-deficient mice. It appears unlikely
that the observed NK cell defect is a result of the abnor- Experimental Procedures
malities in T cell activation or B cell development seen
Generation of Ets-1-Deficient Micein the Ets-12/2 mice, because normal NK cells develop
The targeting vector used to produce the deletion of exons 3 andin the absence of T and B cells in both SCID and RAG2-
4 of the murine Ets-1 gene has been described previously (Muthu-deficient animals (Trinchieri, 1989; Moore et al., 1996).
samy et al., 1995). RW ES cells were electroporated and selected
Because Ets-1 is expressed at high levels in mature by growth in G418 and ganciclovir. ES cell clones containing the
NK cells, the simplest model to explain our findings is targeted deletion of the Ets-1 gene were identified by Southern blot
that Ets-1 regulates the expression of NK cell genes that analysis with a 0.9 kb XbaI/BglII probe (probe A, Figure 1B) and
were injected into C57BL/6 blastocysts to produce chimeras. Chi-are required for the normal development or survival of
meric males were mated with C57BL/6 females, and the resultingthe lineage; i.e., the defect seen in the Ets-12/2 mice is
agouti pups were genotyped by Southern blot analysis with a 1.0intrinsic to the NK cells or their precursors. However,
kb XbaI probe (probe B, Figure 1B). Mice heterozygous for the
we cannot at present rule out the possibility that Ets-1 Ets-1 deletion were interbred to produce Ets-1-deficient mice. Age-
instead regulates the expression of non-NK cell cyto- matched Ets-12/2 and wild-type 6- to 12-week-old mice were used
kines or cell surface receptors, which in turn modulate for all NK studies. All animal experimentation was carried out in the
FMI animal facility of the University of Chicago in accordance withthe differentiation of NK cells in a paracrine fashion. A
NIH guidelines.more definitive answer to this question will await the
results of experiments in which Ets-1-deficient bone
Immunoblottingmarrow is transplanted into lethally irradiated wild-type
Whole-cell extracts from 0.5 3 106 thymocytes; 0.5 3 106 flow-sortedhosts (and vice versa).
DX51/CD32 splenocytes; or 4 3 106 Ets-11/1, Ets-12/1, or Ets-12/2
Our preliminary studies have suggested that the de- splenocytes were subjected to immunoblot analysis with the Ets-
fect in TCR-mediated activation observed in the Ets-1- 1-specific rabbit polyclonal antiserum C-20 (Santa Cruz) (2 mg/ml).
deficient T cells reflects abnormalities in membrane-proxi-
mal signaling events. Thus, for example, the Ets-12/2 T Flow Cytometry
Single-cell suspensions were obtained by mechanical disruption.cells display markedly reduced activation following TCR
Cells (0.5 3 106 to 1.0 3 106) were blocked with anti-Fc receptor andcross-linking. This defect is associated with decreased
stained on ice for 30 min with phycoerythrin (PE)- and fluoresceintryrosine phosphorylation and activation of LAT and
isothiocyanate (FITC)-conjugated antibodies. The antibodies used in
ZAP70, two proximal T cell signal transduction mole- these experiments included anti-Fc-g III/II (2.4 G2), anti-CD3 (2C11),
cules (T. W. et al., unpublished data). These results have anti-CD4 (RM4±5), anti-CD8 (53±6.7), anti-B220 (RA3±6B2), anti-IgM
suggested a working model in which Ets-1 regulates the (II/41), anti-DX5 (DX5) and anti-NK-1.1 (PK136), and anti-IL-2Rb (TM-
b1) (PharMingen). The DX5 antibody recognizes an unknown epitopeexpression of one or more proximal signal transduction
on most or all NK cells from all known mouse strains and is thereforemolecules in wild-type resting T cells. Recent studies
a useful reagent for identifying NK cells in gene-targeted mice pro-have suggested that the development and activation of
duced from C57BL/6-129 chimeras. This epitope appears to be
NK cells and T cells may be mediated at least in part distinct from NKR-P1, CD56, or CD94. Cells were washed and two-
by common proximal signal transduction pathways color flow cytometric analyses were performed on a FACScan (Bec-
(Leibson, 1997). For example, cross-linking of the a/b ton-Dickinson). Gating for viable cells was performed using propid-
ium iodide exclusion. Each plot represents analysis of more thanTCR is known to result in phosphorylation of ITAM-con-
104 events using Lysis II software.taining CD3 molecules, which in turn recruit and activate
the ZAP70 protein tyrosine kinase, leading to the tyro-
Measurement of Serum IgMsine phosphorylation of a set of downstream signaling
Serum IgM levels were measured by ELISA (Su et al., 1997) usingmolecules (Qian and Weiss, 1997). Similarly, in NK cells,
the Clonotyping System/AP (Southern Biotechnology Associates).
KIR molecules lacking ITIM motifs have recently been The enzymatic reaction was developed with p-NPP phosphatase
reported to interact with the ITAM-containing adapter Substrate System (Kirkegaard & Perry Laboratories) according to
DAP12, which in turn appears to activate ZAP70 and the manufacturer's recommendations.
Syk protein tyrosine kinases leading to the phosphoryla-
tion of downstream signaling molecules and NK cell Measurement of IFNg
Splenocytes were cultured in vitro for 18 hr with poly (I:C) (100 mg/activation. Given these similarities, it is tempting to
ml). Supernatants were removed and IFNg measured by ELISA usingspeculate that Ets-1 may regulate the expression of one
the murine IFNg Endogen MiniKit according to the manufacturer'sor more proximal signal transduction molecules that are
instructions.
important for both thymocyte and NK cell development.
In such a model, the decreased expression of such sig-
In Vitro Cytotoxicity
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